Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Robert Langer
Biotech
Novo Nordisk inks $2.1B oral drug delivery pact
The new technology comes from Vivtex, a drug delivery specialist that spun out of the MIT lab of biotech legend Robert Langer in 2018.
Darren Incorvaia
Feb 25, 2026 8:00am
Langer-backed biotech looks to end cancer recurrence
Feb 12, 2026 8:00am
RNA biotech Soufflé rises with $200M and Big Pharma partners
Oct 7, 2025 3:30pm
Biotech veteran Robert Langer joins son launching new VC
Sep 18, 2025 3:15pm
Langer spinout Lyndra begins winding down, lays off staff
Mar 27, 2025 10:58am
Langer steps down from Moderna board after 14 years
Jul 23, 2024 12:18pm
